Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Page Not Found
Cart summary

You have no items in your shopping cart.

Fostemsavir Tris

SKU: orb1309917

Description

Fostemsavir Tris (BMS-663068 Tris) is an oral prodrug of the active attachment inhibitor BMS-626529. It blocks HIV-1 infection by binding to viral gp120, preventing its attachment to host CD4+ T-cells. This mechanism has been validated in both in vitro antiviral assays and in vivo clinical research for antiretroviral therapy.

Research Area

Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry

Images & Validation

Key Properties

CAS Number864953-39-9
MW704.62
Purity99.45% (May vary between batches)
FormulaC29H37N8O11P
SMILESO=C(N1CCN(C(C2=CC=CC=C2)=O)CC1)C(C3=CN(COP(O)(O)=O)C4=C3C(OC)=CN=C4N5N=C(C)N=C5)=O.OCC(CO)(N)CO
TargetHIV Protease
SolubilityH2O:100 mg/mL (141.92 mM);DMSO:125 mg/mL (177.4 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (5.68 mM)

Bioactivity

In Vivo
BMS-663068 is the phosphonooxymethyl prodrug of BMS-626529, a novel small-molecule attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4(+) T cells.The activity of BMS-626529 is virus dependent, due to heterogeneity within gp120. BMS-626529 had half-maximal effective concentration (EC(50)) values of <10 nM against the vast majority of viral isolates; however, susceptibility varied by >6 log(10), with half-maximal effective concentration values in the low pM range against the most susceptible viruses. The in vitro antiviral activity of BMS-626529 was generally not associated with either tropism or subtype, with few exceptions. Measurement of the binding affinity of BMS-626529 for purified gp120 suggests that a contributory factor to its inhibitory potency may be a relatively long dissociative half-life.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

BMS663068, BMS-663068, BMS-663068 Tris, BMS 663068, inhibit, Inhibitor, HIV, HIV Protease, HIV-1, HIVProtease, Fostemsavir, Fostemsavir Tris, Human immunodeficiency virus

Similar Products

  • Fostemsavir Tris [orb1219369]

    >98% (HPLC)

    864953-39-9

    704.62

    C29H37N8O11P

    2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Fostemsavir Tris (orb1309917)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 80.00
5 mg
$ 120.00
10 mg
$ 150.00
1 ml x 10 mM (in DMSO)
$ 160.00
25 mg
$ 220.00
50 mg
$ 320.00
100 mg
$ 430.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry